IRT decisions can make or break clinical supply. Craig Mooney explains how configuration, enrollment, inventory, and human oversight shape trial execution.
- Building Stronger Sponsor–Vendor Relationships
- When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- Managing Customs, Import/Export Requirements, And Cross-Border Logistics Challenges
- July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
- Fast, Secure, And Defensible: Building Decisions That Can Be Challenged Internally And Defended Externally
- Cold Chain Excellence: Safeguarding Biologics, Cell Therapies, And Temperature-Sensitive Products In Complex Logistics
- How AI Can Improve Clinical Supply Chain Visibility
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Enhancing Clinical Supply Chain With Signant SmartSignals Supplies
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
Faster From Formulation To Fill/Finish
Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
Breaking Down Early Small Molecule Development
Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
Is Your Clinical Supply Chain Fully Optimized?
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
3 IRT Tactics Being Used To Streamline Supply Logistics
Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.
-
Investigational Medicinal Products: Labeling Changes And Their Implications
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
Common RTSM/IRT AN Medication Pooling Questions Answered
Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
Ensure Seamless, Efficient Delivery Of Clinical Trial Materials Worldwide
Drug discovery companies, CROs, and CDMOs are under pressure to find supply management solutions that ensure delivery of clinical trial materials while navigating complex study designs and the regulatory landscape.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.